FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
- Is Lear, Back From Bankruptcy, a Buy?
- Sanofi-Aventis Falling Off a Patent Cliff?
- Cramer: Your Thanksgiving Week Game Plan
- Cramer: Next Week Should Define Rest of ‘09
- Mad Money: Mad Mail: Buy RIM or Apple?
- Lightning Round: Cisco Systems, Citigroup, Baidu.com and More
- Lightning Round OT: Martek Biosciences, Valmont Industries and More

MAD MONEY FEATURES
Watch the Lightning Round whenever and wherever you want.
Missed an episode of Mad Money? Watch the lastest show here.
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.
Admit it: You’ve always wanted to hit the “They know nothing!” button. Here’s your chance.
Check out the Mad Money host on set, back to school, behind the scenes and more.
Get all your favorite Cramer clips right here.
Buy Cramer books, bobbleheads and other Mad Money merchandise.
Pick up the phone! It’s Cramer! New Mad Money sounds for your cell phone.
Mad Money’s mobile. Get show highlights sent to your phone.
Cramer says: “There’ll be many failed banks coming up – many, many. What’s going to happen – and we’re going to have [FDIC Chairwoman] Sheila Bair on the show tomorrow – you’re going to see banks that are well capitalized, like First Niagara, being able to buy other banks that get in trouble. That’s why I like FNFG. It reminds me very much of some of the banks, like Fleet, that I invested in, in the late ‘80s.”
___
Jim: I started purchasing Pfizer [PFE
Loading...
()
] early this year because of the acquisition of Wyeth [WYE
Loading...
()
]. With the acquisition it was said that PFE would be able to see some great profits and returns from the deal. Now with health care and pharma being on Obama's hit list, how could this impact PFE's stock and will it? Thank you for your time and a great big Army Booyah! --Jerome
Cramer says: “Thank you for serving…Pfizer I just don’t think has anything going for it. I don’t think the merger’s going to matter. I think it’s a deadweight stock, and I don’t want you buying Pfizer.”
Watch the video for Cramer’s calls on CardioNet [BEAT
Loading...
()
] and Cougar Biotechnology [CGRB
Loading...
()
].
Call Cramer: 1-800-743-CBNC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?



